Patents Assigned to IAF BioChem International, Inc.
  • Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus
    Patent number: 5164481
    Abstract: Linear and cyclic peptides of the E1 and C protein of the rubella virus are disclosed. These peptides and analogues, mixtures and combinations of them are useful in detecting and quantifying antibodies raised against the rubella virus. They are also useful in raising antibodies to the rubella virus for use in the diagnosis of and protection against rubella viral infections.
    Type: Grant
    Filed: August 23, 1989
    Date of Patent: November 17, 1992
    Assignee: IAF Biochem International Inc.
    Inventors: Martial Lacroix, Maan Zrein, Gervais Dionne
  • 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
    Patent number: 5047407
    Abstract: Methods and compositions for preventing or treating human immunodeficiency virus (HIV) infections characterized by 2-substituted-5-substituted-1,3-oxathiolanes.
    Type: Grant
    Filed: February 8, 1989
    Date of Patent: September 10, 1991
    Assignee: IAF BioChem International, Inc.
    Inventors: Bernard Belleau, Nghe Nguyen-Ba
  • 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections
    Patent number: 5041449
    Abstract: There are provided novel 2-substituted-4-substituted-1,3-dioxolanes which are particularly useful as antiviral agents.
    Type: Grant
    Filed: June 29, 1990
    Date of Patent: August 20, 1991
    Assignee: IAF BioChem International, Inc.
    Inventors: Bernard Belleau, Dilip Dixit, Nghe Nguyen-Ba